ISSN 1006-298X      CN 32-1425/R

导航

肾脏病与透析肾移植杂志 ›› 2026, Vol. 35 ›› Issue (2): 126-133.DOI: 10.3969/j.issn.1006-298X.2026.02.005

• 论著 • 上一篇    下一篇

KRAS 基因突变导致狼疮肾炎的临床及基因型特征分析

  

  • 出版日期:2026-04-28 发布日期:2026-04-23

Clinical and genotypic features of lupus nephritis patients with KRAS mutations

  • Online:2026-04-28 Published:2026-04-23

摘要: 目的:探讨携带 KRAS 基因突变的狼疮肾炎 (LN) 患者的表型和基因型特征。方法:收集经全外显子或全基因组测序检出携带 KRAS 致病变异的 LN 患者的临床和病理资料,分析其基因变异位点、临床表现、肾脏病理及治疗转归。结果:共鉴定 5 例携带 KRAS 致病性杂合突变的 LN 患者,携带 4 个突变位点:3 个错义突变 (G13D、V114A、A146V) 和 1 个框内缺失突变 E175del。所有患者均有显著血液系统异常包括全血细胞减少 (n=5) 和持续性单核细胞增多 (n=2),3 例伴脾大或淋巴结肿大。肾脏病理表现异质性强,包括从轻度系膜病变到重度弥漫增生伴新月体形成的全谱系病理改变。临床治疗多采用糖皮质激素联合免疫抑制剂的方案,4 例达完全或部分缓解,1 例疗效不佳并进展至终末期肾病。结论:携带 KRAS 基因变异的 LN 患者具有独特临床表型,对部分早发、伴显著血液学异常者进行基因筛查可能有助于识别潜在遗传病因,并为靶向治疗提供线索。

关键词: 狼疮肾炎, KRAS, 致病变异, 自身免疫

Abstract: Objective:To investigate the phenotypic and genotypic characteristics of lupus nephritis (LN) patients with KRAS mutations. Methods:Clinical and pathological data were collected from LN patients carrying pathogenic KRAS variants identified by whole-exome sequencing or whole-genome sequencing.Genetic profiles,clinical manifestations,renal pathology and treatment outcomes were integrated for analysis. Results:Five LN patients with heterozygous pathogenic KRAS mutations were identified,involving 4 distinct variants:3 missense (G13D,V114A,A146V) and one in-frame deletion (E175del). All patients had notable hematologic abnormalities, including pancytopenia (n=5) and persistent monocytosis (n=2):3 paients preented with splenomegaly or lymphadenopathy. Renal pathology was highly heterogeneous,ranging from mild mesangial lesions to severe diffuse proliferative glomerulonephritis with crescent formation. Treatment mainly involved glucocorticoids combined with immunosuppressants;4 patients achieved complete or partial remission,while one showed poor response and progressed to end-stage renal disease. Conclusion:LN patients with KRAS variants present a subset of distinct clinical phenotypes.Genetic screening in individuals with early-onset disease (in some cases) or prominent hematologic abnormalities may help identify underlying genetic causes and inform potential therapies targeting Ras-MAPK pathway.

Key words: lupus nephritis,KRAS,pathogenic variant,autoimmunity